TargetMol

PG 931 acetate

Product Code:
 
TAR-TP1953L
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-TP1953L-1mg1mg£405.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1953L-5mg5mg£822.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1953L-10mg10mg£1,091.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1953L-25mg25mg£1,589.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1953L-50mg50mg£2,119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-TP1953L-100mg100mg£2,825.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
PG-931 acetate is a potent agonist of melanocortin 4 (MC4) receptors.
CAS:
0
Formula:
C61H89N15O13
Molecular Weight:
1240.45
Pathway:
GPCR/G Protein
Purity:
0.9874
SMILES:
O=C(N[C@@H](CCCCNC(C[C@@]1([H])NC([C@@H](NC(C)=O)CCCC)=O)=O)C(N(CCC2)[C@@H]2C(N[C@H](C(N)=O)C(C)C)=O)=O)[C@@H](NC([C@H](NC([C@H](NC([C@@](CCC3)([H])N3C1=O)=O)CC4=CC=CC=C4)=O)CCCNC(N)=N)=O)CC5=CNC6=CC=CC=C56.CC(O)=O
Target:
Melanin-concentrating Hormone Receptor (MCHR)

References

D Giuliani, et al. Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage. Br J Pharmacol. 2007 Mar;150(5):595-603.